Literature DB >> 16033681

Can statins reduce the incidence of new-onset diabetes post transplantation?

Boaz Hirshberg1.   

Abstract

Entities:  

Year:  2005        PMID： 16033681     DOI： 10.1007/s11892-005-0025-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  9 in total

1.  New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view.

Authors:  Jaime A Davidson; Alan Wilkinson
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

2.  Incidence and predictors of myocardial infarction after kidney transplantation.

Authors:  Krista L Lentine; Daniel C Brennan; Mark A Schnitzler
Journal:  J Am Soc Nephrol       Date:  2004-12-22       Impact factor: 10.121

3.  Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

Authors:  D J Freeman; J Norrie; N Sattar; R D Neely; S M Cobbe; I Ford; C Isles; A R Lorimer; P W Macfarlane; J H McKillop; C J Packard; J Shepherd; A Gaw
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

4.  Diabetes mellitus after kidney transplantation in the United States.

Authors:  Bertram L Kasiske; Jon J Snyder; David Gilbertson; Arthur J Matas
Journal:  Am J Transplant       Date:  2003-02       Impact factor: 8.086

5.  Impact of diabetes mellitus on kidney transplant recipients in Spain.

Authors:  Jose Manuel González-Posada; Domingo Hernández; Beatriz Bayés Genís; Javier García Perez; Manuel Rivero Sanchez
Journal:  Nephrol Dial Transplant       Date:  2004-06       Impact factor: 5.992

6.  fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.

Authors:  Alan G Jardine; Hallvard Holdaas; Bengt Fellström; Edward Cole; Gudrun Nyberg; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Bart Maes; Patrice Ambühl; Anders G Olsson; Ingar Holme; Per Fauchald; Claudio Gimpelwicz; Terje R Pedersen
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

7.  Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.

Authors:  Bengt Fellström; Hallvard Holdaas; Alan G Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Edward Cole; Bart Maes; Patrice Ambühl; Anders G Olsson; Anders Hartmann; John O Logan; Terje R Pedersen
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

8.  Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins).

Authors:  G V Ramesh Prasad; S Joseph Kim; Michael Huang; Michelle M Nash; Jeffrey S Zaltzman; Stanley S A Fenton; Daniel C Cattran; Edward H Cole; Carl J Cardella
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

9.  Diabetes mellitus in transplantation: 2002 consensus guidelines.

Authors:  R Moore; A Boucher; J Carter; S J Kim; B Kiberd; R Loertscher; J G Mongeau; G V R Prasad; L Vautour
Journal:  Transplant Proc       Date:  2003-06       Impact factor: 1.066
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.